Literature DB >> 22190591

Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages.

Takahiro Mimae1, Morihito Okada, Man Hagiyama, Yoshihiro Miyata, Yasuhiro Tsutani, Takao Inoue, Yoshinori Murakami, Akihiko Ito.   

Abstract

PURPOSE: Lung adenocarcinoma often manifests as tumors with mainly lepidic growth. The size of invasive foci determines a diagnosis of in situ, minimally invasive adenocarcinoma, or invasive types and suggests that some adenocarcinomas undergo malignant progression in that order. This study investigates how transcriptional aberrations in adenocarcinoma cells at the early stage define the clinical phenotypes of adenocarcinoma tumors at the advanced stage. EXPERIMENTAL
DESIGN: We comprehensively searched for differentially expressed genes between preinvasive and invasive cancer cells in one minimally invasive adenocarcinoma using laser capture microdissection and DNA microarrays. We screened expression of candidate genes in 11 minimally invasive adenocarcinomas by reverse transcriptase PCR and examined their involvement in preinvasive-to-invasive progression by transfection studies. We then immunohistochemically investigated the presence of candidate molecules in 64 samples of advanced adenocarcinoma and statistically analyzed the findings, together with clinicopathologic variables.
RESULTS: The transcription factors Notch2 and Six1 were upregulated in invasive cancer cells in all 11 minimally invasive adenocarcinomas. Exogenous Notch2 transactivated Six1 followed by Smad3, Smad4, and vimentin, and enlarged the nuclei of NCI-H441 lung epithelial cells. Immunochemical staining for the transcription factors was double positive in the invasive, but not in the lepidic growth component of a third of advanced Ads, and the disease-free survival rates were lower in such tumors.
CONCLUSIONS: Paired upregulation of Notch2 and Six1 is a transcriptional aberration that contributes to preinvasive-to-invasive adenocarcinoma progression by inducing epithelial-mesenchymal transition and nuclear atypia. This aberration persisted in a considerable subset of advanced adenocarcinoma and conferred a more malignant phenotype on the subset. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190591     DOI: 10.1158/1078-0432.CCR-11-1946

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  30 in total

1.  MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1.

Authors:  Jenean H O'Brien; Laura Hernandez-Lagunas; Kristin Bruk Artinger; Heide L Ford
Journal:  J Cell Sci       Date:  2014-03-14       Impact factor: 5.285

2.  Inhibition of Six1 promotes apoptosis, suppresses proliferation, and migration of osteosarcoma cells.

Authors:  Liu Hua; Liu Fan; Wei Aichun; Zhou Yongjin; Chen Qingqing; Wang Xiaojian
Journal:  Tumour Biol       Date:  2013-10-11

Review 3.  The SIX1-EYA transcriptional complex as a therapeutic target in cancer.

Authors:  Melanie A Blevins; Christina G Towers; Aaron N Patrick; Rui Zhao; Heide L Ford
Journal:  Expert Opin Ther Targets       Date:  2015-01-02       Impact factor: 6.902

4.  Modest Static Pressure Can Cause Enteric Nerve Degeneration Through Ectodomain Shedding of Cell Adhesion Molecule 1.

Authors:  Azusa Yoneshige; Man Hagiyama; Takao Inoue; Tomonori Tanaka; Aritoshi Ri; Akihiko Ito
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

5.  Structure-activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphatase.

Authors:  Jothi Anantharajan; Nithya Baburajendran; Grace Lin; Yong Yao Loh; Weijun Xu; Nur Huda Binte Ahmad; Shuang Liu; Anna E Jansson; John Wee Liang Kuan; Elizabeth Yihui Ng; Yee Khoon Yeo; Alvin W Hung; Joma Joy; Jeffrey Hill; Heide L Ford; Rui Zhao; Thomas H Keller; CongBao Kang
Journal:  Protein Sci       Date:  2021-11-18       Impact factor: 6.725

6.  A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal.

Authors:  Yanyan Zheng; Cecile C de la Cruz; Leanne C Sayles; Chris Alleyne-Chin; Dedeepya Vaka; Tim D Knaak; Marty Bigos; Yue Xu; Chuong D Hoang; Joseph B Shrager; Hans Joerg Fehling; Dorothy French; William Forrest; Zhaoshi Jiang; Richard A D Carano; Kai H Barck; Erica L Jackson; E Alejandro Sweet-Cordero
Journal:  Cancer Cell       Date:  2013-07-08       Impact factor: 31.743

7.  Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.

Authors:  Jothi Anantharajan; Hengbo Zhou; Lingdi Zhang; Taylor Hotz; Melanie Y Vincent; Melanie A Blevins; Anna E Jansson; John Wee Liang Kuan; Elizabeth Yihui Ng; Yee Khoon Yeo; Nithya Baburajendran; Grace Lin; Alvin W Hung; Joma Joy; Samarjit Patnaik; Juan Marugan; Pratyaydipta Rudra; Debashis Ghosh; Jeffrey Hill; Thomas H Keller; Rui Zhao; Heide L Ford; CongBao Kang
Journal:  Mol Cancer Ther       Date:  2019-07-08       Impact factor: 6.261

8.  Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.

Authors:  Aaron N Patrick; Joshua H Cabrera; Anna L Smith; Xiaojiang S Chen; Heide L Ford; Rui Zhao
Journal:  Nat Struct Mol Biol       Date:  2013-02-24       Impact factor: 15.369

9.  Next-generation sequencing-based identification of EGFR and NOTCH2 complementary mutations in non-small cell lung cancer.

Authors:  Lin Niu; Chunyan Dang; Lin Li; Na Guo; Ying Xu; Xiangling Li; Qian Xu; Luyang Cheng; Li Zhang; Lei Liu
Journal:  Oncol Lett       Date:  2021-06-07       Impact factor: 2.967

10.  The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis.

Authors:  Man Hagiyama; Azusa Yoneshige; Takao Inoue; Yasufumi Sato; Takahiro Mimae; Morihito Okada; Akihiko Ito
Journal:  J Biomed Sci       Date:  2015-08-11       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.